Patents by Inventor Kadoaki OHASHI

Kadoaki OHASHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AGENT FOR EGFR GENE MUTATION-POSITIVE LUNG CANCER COMPRISING REIC/Dkk-3 GENE
    Publication number: 20230310653
    Abstract: This invention provides a therapeutic method for treatment of EGFR gene mutation-positive lung cancer using the REIC/Dkk-3 gene in combination with the EGFR tyrosine kinase inhibitor, the PD-1/-L1 immune checkpoint pathway inhibitor, and/or the molecular-targeted agent. This invention provides a therapeutic agent comprising, as an active ingredient, the REIC/Dkk-3 gene, which is used in combination with the EGFR tyrosine kinase inhibitor, the PD-1/-L1 immune checkpoint pathway inhibitor, and/or the molecular-targeted agent for treatment of EGFR gene mutation-positive lung cancer.
    Type: Application
    Filed: July 29, 2021
    Publication date: October 5, 2023
    Applicant: Momotaro-Gene Inc.
    Inventors: Hiromi KUMON, Kadoaki OHASHI, Katsuyuki KIURA, Yoshinobu MAEDA, Takamasa NAKASUKA, Kazuya NISHII